Perimenopause: Which Blood Tests Actually Help?

Perimenopause is the 4-10 year transition leading up to menopause (defined as 12 consecutive months without a period). For most women, it starts in the late 30s or early 40s — well before most doctors think to test for hormonal changes. The average age of menopause in the US is 51, which means perimenopause typically begins around 41-44, though it can start as early as 35.

The hallmark of perimenopause isn't low hormones — it's fluctuating hormones. Estrogen levels often swing dramatically week to week, sometimes higher than normal and sometimes lower. Progesterone drops earlier and more consistently as ovulation becomes less regular. FSH (follicle-stimulating hormone) rises as the ovaries become less responsive. Testosterone gradually declines, contributing to changes in energy, libido, and muscle mass.

This variability is why a single blood test can be misleading. An estradiol reading on day 14 of one cycle might be 250 pg/mL (perfectly normal), while a reading two weeks later or one cycle later might be 30 pg/mL. Neither result on its own diagnoses perimenopause — but the pattern of symptoms PLUS supportive bloodwork is highly diagnostic. Doctors often dismiss women's symptoms because "your hormones are normal on the day we tested" — which misses that perimenopause IS the abnormality of variability, not absolute levels.

This is why we recommend a comprehensive panel that covers multiple hormones simultaneously. The pattern across all of them (e.g., low progesterone + variable estradiol + rising FSH + symptomatic) is meaningfully more diagnostic than any single marker. And it gives you data to bring to a knowledgeable provider — a NAMS-certified menopause practitioner, a women's-health endocrinologist, or a functional medicine doctor who treats based on the complete picture rather than dismissing symptomatic women with "your labs are normal."

Progesterone — the first to drop. Progesterone is produced after ovulation, so as ovulation becomes less regular or stops happening in some cycles (anovulatory cycles), progesterone declines first — typically starting in the late 30s. Low progesterone causes shorter or longer cycles, heavier or lighter periods, breast tenderness, sleep disruption (progesterone has a calming effect on the brain), and anxiety. Optimal day-21 progesterone in a still-cycling woman is above 10 ng/mL; below 5 ng/mL suggests anovulation.

Estradiol — the variable one. Estradiol fluctuates more dramatically in perimenopause than it ever did in earlier reproductive years. Some cycles produce very high estradiol (causing heavy periods, breast tenderness, headaches, fibroid growth); others produce very low estradiol (causing hot flashes, night sweats, vaginal dryness, mood swings). A single estradiol reading rarely tells the full story; the symptom pattern often reveals more than the number. Postmenopausal estradiol typically settles below 30 pg/mL.

FSH — the rising signal. FSH is produced by the pituitary to stimulate the ovaries. As ovarian reserve declines, the pituitary cranks up FSH trying to get a response. FSH above 25-30 mIU/mL on day 3 of a cycle suggests advancing perimenopause; FSH consistently above 40 mIU/mL with absent periods confirms menopause. Note: FSH can be falsely normal on hormonal birth control (which suppresses the pituitary), so testing requires being off birth control for at least 6 weeks.

LH — pairs with FSH. Luteinizing hormone follows similar patterns to FSH. The FSH:LH ratio also matters — in PCOS, LH is typically higher than FSH; in perimenopause, FSH typically rises higher than LH. Useful for distinguishing perimenopause from other hormonal patterns that share symptoms.

Testosterone (Total + Free). Often forgotten in women's hormone evaluation, but testosterone matters for libido, energy, mood, and muscle mass. Women's testosterone declines gradually starting in the 30s and drops more sharply around menopause. SHBG (sex hormone-binding globulin) rises with age, which means even normal total testosterone can be functionally low due to less unbound (free) testosterone available to tissues. The full picture requires Total + Free Testosterone + SHBG.

DHEA-S. The adrenal androgen that converts to testosterone and estrogen in peripheral tissues. DHEA-S declines steadily from the 30s onward and is sometimes used as a marker of "adrenal reserve." Low DHEA-S can contribute to fatigue, low libido, and reduced sense of well-being in perimenopause.

Perimenopause coincides with several other health shifts that are easy to attribute to "just hormones" but deserve independent investigation:

Thyroid panel (TSH + Free T4). Thyroid dysfunction (especially Hashimoto's thyroiditis) peaks in women aged 40-60 — the same window as perimenopause. The symptom overlap is enormous: fatigue, weight gain, hair thinning, mood changes, cognitive fog, cold intolerance. It's common for women to be told "it's just perimenopause" when they have undiagnosed Hashimoto's. Always check TSH + Free T4 when investigating perimenopausal symptoms; add TPO Antibodies if TSH is elevated.

Vitamin D, 25-Hydroxy. Critical for bone health, which becomes increasingly important as estrogen declines (estrogen protects bone density). Vitamin D deficiency is common in women in this age range and contributes to fatigue, mood changes, and bone loss. Optimal range for bone protection is 40-60 ng/mL.

Hemoglobin A1c + Fasting Insulin. Estrogen decline shifts insulin sensitivity, often causing weight gain (especially abdominal) and increased diabetes risk in the 5-10 years around menopause. Catching insulin resistance early — when fasting insulin is rising but A1c is still normal — gives the most reversible window for intervention. The Diabetes Screening Panel ($59.99) bundles A1c, fasting glucose, and fasting insulin.

Lipid panel + ApoB. Cardiovascular risk increases significantly post-menopause as estrogen's cardioprotective effects fade. Establishing a baseline ApoB and lipid panel in your 40s gives you the trajectory to manage with diet, exercise, or medication if needed. The Heart Health Panel ($74.99) covers this comprehensively.

Bone density markers (optional). While DEXA scans are the gold standard for bone density measurement, blood markers like Vitamin D, Calcium, and (in some cases) Parathyroid Hormone (PTH) provide useful context. Most women don't need a DEXA scan until age 65, but if you have early menopause, family history of osteoporosis, or other risk factors, earlier baseline testing is sensible.

Hormone testing is more nuanced than most other bloodwork. The timing matters because hormones cycle throughout the month (in still-cycling women) and follow circadian patterns within the day.

For still-cycling women:

• FSH, LH, Estradiol: Test on day 2-5 of your cycle (counting day 1 as the first day of bleeding). This is the "baseline" hormonal state before ovulation and gives the most diagnostic snapshot for assessing perimenopausal trajectory.
• Progesterone: Test on day 21 of a 28-day cycle (or roughly 7 days before expected period in cycles of other lengths). This is the peak progesterone window after ovulation. Low progesterone here suggests anovulation.
• Testosterone, DHEA-S, SHBG, Prolactin: Can be tested any day, but morning draws (7-10 AM) are best because testosterone follows a circadian rhythm.
• Thyroid (TSH + Free T4): Any day, morning preferred.

For women with irregular or absent cycles:

• Test any day — the cycle has lost predictability, so "day of cycle" no longer matters. Morning draws still preferred for testosterone and thyroid accuracy.
• FSH consistently above 25-30 mIU/mL with irregular periods suggests late perimenopause; consistently above 40 mIU/mL with absent periods for 12 months confirms menopause.

Birth control considerations: Hormonal birth control (pill, patch, ring, IUD with hormones) suppresses FSH and provides synthetic estrogen/progesterone, making hormone testing essentially uninterpretable for assessing your body's natural levels. If you're on hormonal birth control and want to assess your natural hormonal state, you'd need to be off it for at least 6 weeks (preferably longer) before testing. This is a real consideration that's worth discussing with your provider before testing.

Biotin warning: If you take biotin supplements (common in hair, skin, nail formulas), stop them 72 hours before the draw — biotin interferes with several hormone immunoassays and can produce false readings.

What to do with your results: Bring them to a NAMS-certified menopause practitioner (find one at menopause.org), a women's-health endocrinologist, or a functional medicine doctor who specializes in women's hormonal health. Many primary care doctors are undertrained in perimenopause management; you'll get more from a specialist. Treatment options range from lifestyle interventions to hormone replacement therapy (HRT) — the most rigorous evidence supports HRT for women within 10 years of menopause without contraindications, and the cardiovascular and bone-density benefits often outweigh the risks for symptomatic women.